GlassScriptPhysician profile
Erin L Smith
NPI 1205473253
$13,072.11
in general payments reported to CMS, 2019-2025
55 companies · $3,040 in 2025
The $3,040 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,298 · 2022: $2,462 · 2023: $2,500 · 2024: $3,772 · 2025: $3,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,312.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,136.11 | 2021-2025 | |
| Pfizer INC. | $1,017.90 | 2022-2025 | |
| Ucb, INC. | $956.04 | 2021-2025 | Fintepla, Nayzilam, Rystiggo |
| Novartis Pharmaceuticals Corporation | $689.51 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $495.55 | 2021-2025 | Ultomiris, Soliris |
| Biohaven Pharmaceutical Holding Company LTD. | $430.61 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $426.09 | 2021 | |
| Lundbeck LLC | $399.08 | 2021-2025 | Vyepti, Rexulti |
| Biogen, INC. | $398.54 | 2022-2025 | Vumerity, Tysabri, Skyclarys |
| Amgen INC. | $398.02 | 2022-2025 | Uplizna, Aimovig |
| Sk Life Science, INC. | $354.85 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $315.96 | 2021-2025 | Rytary, Crexont |
| Livanova USA, INC. | $290.96 | 2022 | |
| Emd Serono, INC. | $275.85 | 2022-2024 | Mavenclad, Mavenclad |
| Argenx US, INC. | $275.09 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $235.52 | 2024 | Inspire |
| Acadia Pharmaceuticals INC | $229.77 | 2022-2024 | Daybue, Nuplazid |
| Lilly USA, LLC | $215.80 | 2023-2025 | Emgality, Reyvow, Amyvid |
| Genentech USA, INC. | $204.61 | 2022-2025 | Ocrevus, Ocrevus Zunovo |
| Neurocrine Biosciences, INC. | $182.03 | 2021-2025 | Ingrezza, Ongentys |
| Genzyme Corporation | $160.87 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $145.39 | 2023-2024 | Acthar |
| Tanabe Pharma America, INC. | $134.62 | 2022-2025 | Radicava |
| Merz Pharmaceuticals, LLC | $120.57 | 2021-2024 | Xeomin |
| Teva Pharmaceuticals USA, INC. | $118.44 | 2021-2023 | Austedo Xr, Austedo |
| Jazz Pharmaceuticals INC. | $112.65 | 2021-2024 | |
| Impel Pharmaceuticals INC. | $102.02 | 2022-2023 | Trudhesa |
| Otsuka America Pharmaceutical, INC. | $100.24 | 2023-2025 | Rexulti, Nuedexta |
| Ani Pharmaceuticals, INC. | $96.29 | 2023-2025 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $85.51 | 2022-2023 | Wakix |
| Astrazeneca Pharmaceuticals LP | $82.91 | 2021-2025 | Wainua |
| Cala Health, INC. | $72.56 | 2025 | Cala Kiq |
| Acorda Therapeutics, INC | $72.45 | 2021-2022 | |
| Celgene Corporation | $68.84 | 2024-2025 | Zeposia |
| Medtronic, INC. | $64.56 | 2021-2024 | Percept PC Brainsense |
| Tg Therapeutics, INC. | $64.53 | 2023-2025 | |
| Janssen Biotech, INC. | $57.72 | 2025 | |
| Neurelis, INC. | $57.39 | 2023-2024 | Valtoco |
| Avanir Pharmaceuticals, INC. | $54.98 | 2021-2022 | |
| Piramal Critical Care | $54.98 | 2021 | |
| Mdd US Operations, LLC | $31.28 | 2024 | Gocovri |
| Cycle Pharmaceuticals INC | $30.30 | 2025 | Tascenso Odt |
| Eisai INC. | $28.05 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $23.90 | 2025 | |
| Springworks Therapeutics, INC. | $23.15 | 2025 | Gomekli |
| Alnylam Pharmaceuticals INC. | $22.96 | 2023 | Amvuttra |
| Ge Healthcare | $21.31 | 2023 | |
| Supernus Pharmaceuticals, INC. | $20.55 | 2022 | |
| Kyowa Kirin, INC. | $17.81 | 2024 | Nourianz |
| Grifols USA, LLC | $17.10 | 2025 | Gamunex-C |
| Grt US Holding, INC. | $17.02 | 2022 | |
| Boston Scientific Corporation | $16.65 | 2025 | General - Dbs |
| Axsome Therapeutics, INC. | $16.49 | 2025 | Symbravo |
| Sunovion Pharmaceuticals INC. | $15.59 | 2022 | |
| Banner Life Sciences, LLC | $14.54 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.